APO RESEARCH · REPORT
Plasma Protein Therapeutics
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Product & engineering
Understand the product.
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Selected research
Industry Research
Plasma Protein Therapeutics Industry Research Report 2026
Market perspective
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.
Report Scope
Read the full market overview
This report quantifies the global Plasma Protein Therapeutics market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Plasma Protein Therapeutics Market by Company
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Plasma Protein Therapeutics Segment by Type
Coagulation Factor
Immune Globulin
Albumin
Others
Plasma Protein Therapeutics Segment by Application
Hemophilia
PID
Others
Plasma Protein Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Plasma Protein Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Plasma Protein Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Plasma Protein Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Plasma Protein Therapeutics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Plasma Protein Therapeutics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Plasma Protein Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Coagulation Factor
- Immune Globulin
- Albumin
- Others
Applications
- Hemophilia
- PID
- Others
Companies covered
- Shire (Baxalta)
- CSL
- Grifols
- Octapharma
- Kedrion
- LFB Group
- Biotest
- BPL
- RAAS
- CBPO
- Hualan Bio
- Kamada
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Plasma Protein Therapeutics Market Size (2021-2032)
- 2.2.2 Global Plasma Protein Therapeutics Sales (2021-2032)
- 2.2.3 Global Plasma Protein Therapeutics Market Average Price (2021-2032)
- 2.3 Plasma Protein Therapeutics by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Coagulation Factor
- 2.3.3 Immune Globulin
- 2.3.4 Albumin
- 2.3.5 Others
- 2.4 Plasma Protein Therapeutics by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hemophilia
- 2.4.3 PID
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Plasma Protein Therapeutics Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Plasma Protein Therapeutics Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Plasma Protein Therapeutics Revenue of Manufacturers (2021-2026)
- 3.4 Global Plasma Protein Therapeutics Average Price by Manufacturers (2021-2026)
- 3.5 Global Plasma Protein Therapeutics Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Plasma Protein Therapeutics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Plasma Protein Therapeutics, Product Type & Application
- 3.8 Global Manufacturers of Plasma Protein Therapeutics, Established Date
- 3.9 Global Plasma Protein Therapeutics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shire (Baxalta)
- 4.1.1 Shire (Baxalta) Company Information
- 4.1.2 Shire (Baxalta) Business Overview
- 4.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shire (Baxalta) Plasma Protein Therapeutics Product Portfolio
- 4.1.5 Shire (Baxalta) Recent Developments
- 4.2 CSL
- 4.2.1 CSL Company Information
- 4.2.2 CSL Business Overview
- 4.2.3 CSL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CSL Plasma Protein Therapeutics Product Portfolio
- 4.2.5 CSL Recent Developments
- 4.3 Grifols
- 4.3.1 Grifols Company Information
- 4.3.2 Grifols Business Overview
- 4.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Grifols Plasma Protein Therapeutics Product Portfolio
- 4.3.5 Grifols Recent Developments
- 4.4 Octapharma
- 4.4.1 Octapharma Company Information
- 4.4.2 Octapharma Business Overview
- 4.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Octapharma Plasma Protein Therapeutics Product Portfolio
- 4.4.5 Octapharma Recent Developments
- 4.5 Kedrion
- 4.5.1 Kedrion Company Information
- 4.5.2 Kedrion Business Overview
- 4.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Kedrion Plasma Protein Therapeutics Product Portfolio
- 4.5.5 Kedrion Recent Developments
- 4.6 LFB Group
- 4.6.1 LFB Group Company Information
- 4.6.2 LFB Group Business Overview
- 4.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 LFB Group Plasma Protein Therapeutics Product Portfolio
- 4.6.5 LFB Group Recent Developments
- 4.7 Biotest
- 4.7.1 Biotest Company Information
- 4.7.2 Biotest Business Overview
- 4.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Biotest Plasma Protein Therapeutics Product Portfolio
- 4.7.5 Biotest Recent Developments
- 4.8 BPL
- 4.8.1 BPL Company Information
- 4.8.2 BPL Business Overview
- 4.8.3 BPL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 BPL Plasma Protein Therapeutics Product Portfolio
- 4.8.5 BPL Recent Developments
- 4.9 RAAS
- 4.9.1 RAAS Company Information
- 4.9.2 RAAS Business Overview
- 4.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 RAAS Plasma Protein Therapeutics Product Portfolio
- 4.9.5 RAAS Recent Developments
- 4.10 CBPO
- 4.10.1 CBPO Company Information
- 4.10.2 CBPO Business Overview
- 4.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CBPO Plasma Protein Therapeutics Product Portfolio
- 4.10.5 CBPO Recent Developments
- 4.11 Hualan Bio
- 4.11.1 Hualan Bio Company Information
- 4.11.2 Hualan Bio Business Overview
- 4.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Hualan Bio Plasma Protein Therapeutics Product Portfolio
- 4.11.5 Hualan Bio Recent Developments
- 4.12 Kamada
- 4.12.1 Kamada Company Information
- 4.12.2 Kamada Business Overview
- 4.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Kamada Plasma Protein Therapeutics Product Portfolio
- 4.12.5 Kamada Recent Developments
5 Global Plasma Protein Therapeutics Market Scenario by Region
- 5.1 Global Plasma Protein Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Plasma Protein Therapeutics Sales by Region: 2021-2032
- 5.2.1 Global Plasma Protein Therapeutics Sales by Region: 2021-2026
- 5.2.2 Global Plasma Protein Therapeutics Sales by Region: 2027-2032
- 5.3 Global Plasma Protein Therapeutics Revenue by Region: 2021-2032
- 5.3.1 Global Plasma Protein Therapeutics Revenue by Region: 2021-2026
- 5.3.2 Global Plasma Protein Therapeutics Revenue by Region: 2027-2032
- 5.4 North America Plasma Protein Therapeutics Market Facts & Figures by Country
- 5.4.1 North America Plasma Protein Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Plasma Protein Therapeutics Sales by Country (2021-2032)
- 5.4.3 North America Plasma Protein Therapeutics Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Plasma Protein Therapeutics Market Facts & Figures by Country
- 5.5.1 Europe Plasma Protein Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Plasma Protein Therapeutics Sales by Country (2021-2032)
- 5.5.3 Europe Plasma Protein Therapeutics Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Plasma Protein Therapeutics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Plasma Protein Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Plasma Protein Therapeutics Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Plasma Protein Therapeutics Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Plasma Protein Therapeutics Market Facts & Figures by Country
- 5.7.1 South America Plasma Protein Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Plasma Protein Therapeutics Sales by Country (2021-2032)
- 5.7.3 South America Plasma Protein Therapeutics Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Plasma Protein Therapeutics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Plasma Protein Therapeutics Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Plasma Protein Therapeutics Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Plasma Protein Therapeutics Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Plasma Protein Therapeutics Sales by Type (2021-2032)
- 6.1.1 Global Plasma Protein Therapeutics Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Plasma Protein Therapeutics Sales Market Share by Type (2021-2032)
- 6.2 Global Plasma Protein Therapeutics Revenue by Type (2021-2032)
- 6.2.1 Global Plasma Protein Therapeutics Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Type (2021-2032)
- 6.3 Global Plasma Protein Therapeutics Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Plasma Protein Therapeutics Sales by Application (2021-2032)
- 7.1.1 Global Plasma Protein Therapeutics Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Plasma Protein Therapeutics Sales Market Share by Application (2021-2032)
- 7.2 Global Plasma Protein Therapeutics Revenue by Application (2021-2032)
- 7.2.1 Global Plasma Protein Therapeutics Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Plasma Protein Therapeutics Revenue Market Share by Application (2021-2032)
- 7.3 Global Plasma Protein Therapeutics Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Plasma Protein Therapeutics Value Chain Analysis
- 8.1.1 Plasma Protein Therapeutics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Plasma Protein Therapeutics Production Mode & Process
- 8.2 Plasma Protein Therapeutics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Plasma Protein Therapeutics Distributors
- 8.2.3 Plasma Protein Therapeutics Customers
9 Global Plasma Protein Therapeutics Analyzing Market Dynamics
- 9.1 Plasma Protein Therapeutics Industry Trends
- 9.2 Plasma Protein Therapeutics Industry Drivers
- 9.3 Plasma Protein Therapeutics Industry Opportunities and Challenges
- 9.4 Plasma Protein Therapeutics Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst